AUTHORS
La'Ron Browne, MBBS, MSc., George Goshua, MD, SM2, Jane Hankins, MD,MS3
AFFILIATIONS
1 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
2 Yale School of Medicine, New Haven, Connecticut, United States
3 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
ABSTRACT
Introduction/Background: Children with sickle cell disease (SCD) who receive evidence-based treatments are expected to survive into adulthood. However, transition to adult-centered care remains a critically dangerous time, marked by higher acute healthcare utilization and increased mortality. Longer transfer gaps between pediatric and adult care are associated with increased hospitalizations and emergency department (ED) visits. However, the economic value of reducing transfer gaps remains unknown. To fill this gap, we evaluated the cost-effectiveness of transfer timing following a structured SCD transition program within a single center.
Methods: Primary data were derived from participants who completed the transition program (i.e., received transition interventions from ages 12 to 18) and who had healthcare utilization data for up to 24 months after transfer to adult care. Patients were grouped by transfer gap: <2 months, 2-6-months, or >6 months. Negative binomial regression models estimated the adjusted rates of outpatient visits, ED visits, and hospitalizations by transfer group, controlling for sex, and baseline pediatric healthcare utilization, with mortality obtained from a complementary analysis of the same cohort. A decision-analytic model linked each transfer group to a Markov cohort model with health states of engaged adult care, loss to follow-up and death. In addition, ED visits and hospitalizations were modeled as recurrent events returning to the engaged state. Costs included transition-program, outpatient, ED, and inpatient care, reported in 2025 US dollars. Clinical outcomes were parameterized using published SCD-specific health and age utilities and reported in quality-adjusted life years (QALYs). The primary outcome was the net monetary benefit (NMB), capturing health benefit converted into $, reported across all accepted US willingness-to-pay thresholds from a health sector perspective over a 2-year transition program time-horizon. Deterministic and probabilistic sensitivity analyses were performed to evaluate the effect of parameter uncertainty on our conclusion.
Results Among 751 participants, 477 (63%) completed the transition program, and 181 (24%) completed post-transfer 24-month follow-up. Of these, 134 transferred within <2 months, 25 transferred within 2-6-months, and 22 transferred after >6 months; 49.0% were male, and 64.0% had HbSS/SB0-thalassemia. Overall, 88% completed their first adult-care visit within 6 months. Compared with transfer within <2 months, transfer after >6 months was associated with a significantly higher hospitalization rate (adjusted IRR 2.15, 95% CI 1.03-4.82), whereas transfer within 2-6 months was associated with significantly fewer outpatient visits (adjusted IRR 0.53, 95% CI 0.36-0.79). Differences in ED visit rates were not statistically significant. In the economic model, transfer within 2-6 months was the least costly ($107,405) and most effective strategy (1.12 QALY’s), dominating transfer within <2 months ($155,071; 1.11 QALYs) and >6 months ($226,740; 1.10 QALYs). Compared with transfer of care after >6 months, transfer within 2-6-months increased the NMB by $120,500 while transfer within <2 months increased the NMB by approximately $72,400. Hospitalization costs, hospitalization rates, and health-state utility estimates were the principal drivers of model outcomes. In probabilistic sensitivity analysis (5,000 simulations), transfer within 2-6 months was the preferred strategy in 100% of 5,000 Monte Carlo iterations even at the lowest willingness-to-pay threshold of $50,000/QALY.
Conclusion: Completing transfer to adult care within 6 months of completing pediatric care provides greater economic value than a transfer gap greater than 6 months. Transfer within 2-6 months was the preferred strategy, balancing healthcare utilization, costs, and QALYs. These findings support structured transition programs and performance measures that prioritize timely completion of transfer while allowing flexibility within the first 6 months.
DISCLOSURES
La'Ron Browne, MBBS, MSc.: Novonordisk - Consultancy (Includes expert testimony)